These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34185606)

  • 1. Perceptions of Diabetes Technology Use in Cystic Fibrosis-Related Diabetes Management.
    Marks BE; Kilberg MJ; Aliaj E; Fredkin K; Hudson J; Riva D; Román C; Kelly A; Putman MS
    Diabetes Technol Ther; 2021 Nov; 23(11):753-759. PubMed ID: 34185606
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems.
    Marks BE; Williams KM; Sherwood JS; Putman MS
    J Clin Transl Endocrinol; 2022 Mar; 27():100282. PubMed ID: 34917483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis.
    Chan CL; Pyle L; Vigers T; Zeitler PS; Nadeau KJ
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e548-e560. PubMed ID: 34537845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring systems for monitoring cystic fibrosis-related diabetes.
    Toner A; McCloy A; Dyce P; Nazareth D; Frost F
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013755. PubMed ID: 34844283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
    Scully KJ; Sherwood JS; Martin K; Ruazol M; Marchetti P; Larkin M; Zheng H; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Wexler DJ; Putman MS
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1444-e1454. PubMed ID: 34850006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
    Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
    Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes?
    Scheuing N; Badenhoop K; Borkenstein M; Konrad K; Lilienthal E; Laubner K; Naeke A; Rami-Merhar B; Thon A; Wiemann D; Holl RW;
    Pediatr Diabetes; 2015 Feb; 16(1):10-5. PubMed ID: 24984902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Cystic Fibrosis-related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care.
    Potter KJ; Coriati A; Hicks P; Lands LC; McKinney ML; Boudreau V; Bonhoure A; Luca P; Ho J; Tagougui S; Jober A; Pohl M; Rosolowsky ET; Gilmour J; Lam GY; Stephenson AL; Senior PA; Rabasa-Lhoret R; Kherani T
    Can J Diabetes; 2023 Apr; 47(3):263-271.e1. PubMed ID: 36872137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Control IQ Hybrid Closed Loop Technology on Glycemic Control in Adolescents and Adults with Cystic Fibrosis-Related Diabetes.
    Scully KJ; Palani G; Zheng H; Moheet A; Putman MS
    Diabetes Technol Ther; 2022 Jun; 24(6):446-452. PubMed ID: 35020476
    [No Abstract]   [Full Text] [Related]  

  • 12. Gestational and pregestational diabetes in pregnant women with cystic fibrosis.
    Oxman R; Roe AH; Ullal J; Putman MS
    J Clin Transl Endocrinol; 2022 Mar; 27():100289. PubMed ID: 34984172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).
    Mozzillo E; Franceschi R; Piona C; Passanisi S; Casertano A; Pjetraj D; Maltoni G; Calcaterra V; Cauvin V; Cherubini V; D'Annunzio G; Franzese A; Frongia AP; Lombardo F; Lo Presti D; Matteoli MC; Piccinno E; Predieri B; Rabbone I; Scaramuzza AE; Toni S; Zucchini S; Maffeis C; Schiaffini R
    Front Endocrinol (Lausanne); 2021; 12():673539. PubMed ID: 34017312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
    Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
    J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis related diabetes: Medical management.
    Ode KL; Chan CL; Granados A; Moheet A; Moran A; Brennan AL
    J Cyst Fibros; 2019 Oct; 18 Suppl 2():S10-S18. PubMed ID: 31679720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological management of cystic fibrosis related diabetes.
    Moheet A; Moran A
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?
    Zorron M; Marson FAL; Morcillo AM; Gonçalves AC; El Beck MS; Ribeiro JD; Ribeiro AF
    J Bras Pneumol; 2022; 48(2):e20210307. PubMed ID: 35475864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving pediatric endocrinology trainees' knowledge about insulin pumps and continuous glucose monitors with online spaced education: Technology Knowledge Optimization in T1D (TeKnO T1D).
    Marks BE; Waldman G; Reardon K; Terrio S; Kumar A; Stafford DEJ; Garvey KC; Wolfsdorf JI
    Pediatr Diabetes; 2020 Aug; 21(5):814-823. PubMed ID: 32222056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.